Ampersand-backed American Laboratory Products Company, an importer and distributor of immunoassay-based products, agreed to merge with GeneProof, an operator of a molecular diagnostics company. Financial terms were not disclosed. “This strategic connection represents a new chapter in the life of both companies. It will facilitate the entry of GeneProof products into the US market, and similarly, expand the presence of ALPCO products into the EU and around the world. The combination of deep knowledge in the field of molecular diagnostics as well as in the field of immunological diagnostics will bring a significant synergistic effect. The two merged companies intend to use each other's technological experience and rely on the support of our strong partner, Ampersand, for further development," Radek Horvath, GeneProof CEO.